Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).


Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
10 2019
Historique:
received: 01 03 2019
accepted: 10 07 2019
pubmed: 17 8 2019
medline: 12 3 2020
entrez: 17 8 2019
Statut: ppublish

Résumé

Persons living with human immunodeficiency virus (PLHIV) are at increased risk of atherosclerotic cardiovascular disease (ASCVD). In spite of this, uptake of evidence-based clinical interventions for ASCVD risk reduction in the HIV clinic setting is sub-optimal. METHODS: EXTRA-CVD is a 12-month randomized clinical effectiveness trial that will assess the efficacy of a multi-component nurse-led intervention in reducing ASCVD risk among PLHIV. Three hundred high ASCVD risk PLHIV across three sites will be randomized 1:1 to usual care with generic prevention education or the study intervention. The study intervention will consist of four evidence-based components: (1) nurse-led care coordination, (2) nurse-managed medication protocols and adherence support (3) home BP monitoring, and (4) electronic health records support tools. The primary outcome will be change in systolic blood pressure and secondary outcome will be change in non-HDL cholesterol over the course of the intervention. Tertiary outcomes will include change in the proportion of participants in the following extended cascade categories: (1) appropriately diagnosed with hypertension and hyperlipidemia (2) appropriately managed; (3) at treatment goal (systolic blood pressure <130 mm Hg and non-HDL cholesterol < National Lipid Association targets). CONCLUSIONS: The EXTRA-CVD trial will provide evidence appraising the potential impact of nurse-led interventions in reducing ASCVD risk among PLHIV, an essential extension of the HIV care continuum beyond HIV viral suppression.

Identifiants

pubmed: 31419622
pii: S0002-8703(19)30180-2
doi: 10.1016/j.ahj.2019.07.005
pmc: PMC6842690
mid: NIHMS1534976
pii:
doi:

Substances chimiques

Cholesterol 97C5T2UQ7J

Banques de données

ClinicalTrials.gov
['NCT03643705']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-101

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL123341
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL137611
Pays : United States
Organisme : HSRD VA
ID : IK6 HX003161
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142099
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI064518
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

AIDS Care. 2016;28(4):475-82
pubmed: 26479580
Fam Pract. 2014 Dec;31(6):714-22
pubmed: 25121978
BMJ. 2013 Oct 03;347:f5680
pubmed: 24092942
Clin Infect Dis. 2016 Aug 1;63(3):407-13
pubmed: 27143663
J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):370-7
pubmed: 24732872
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
JAMA Intern Med. 2014 Feb 1;174(2):186-93
pubmed: 24247275
BMJ Open. 2016 Nov 3;6(11):e012429
pubmed: 27810973
J Am Heart Assoc. 2014 Apr 10;3(2):e000718
pubmed: 24721801
Cochrane Database Syst Rev. 2016 Jun 13;(6):CD011120
pubmed: 27292836
JAMA. 2013 Aug 21;310(7):699-705
pubmed: 23989679
Arch Intern Med. 2011 Jul 11;171(13):1173-80
pubmed: 21747013
Ann Intern Med. 2009 Nov 17;151(10):687-95
pubmed: 19920269
J Assoc Nurses AIDS Care. 2014 Jan-Feb;25(1):60-9
pubmed: 24070645
Prev Chronic Dis. 2013;10:E10
pubmed: 23347705
J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):342-5
pubmed: 24718379
JAMA. 2016 Sep 27;316(12):1289-97
pubmed: 27673306
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S72-81
pubmed: 24793444
J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1
pubmed: 26699442
Ann Intern Med. 2005 Nov 15;143(10):729-36
pubmed: 16287794
Clin Infect Dis. 2016 Jan 1;62(1):90-98
pubmed: 26324390
JAMA. 2013 Jul 3;310(1):46-56
pubmed: 23821088
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):368-75
pubmed: 22240460
Clin Infect Dis. 2005 Sep 1;41(5):738-43
pubmed: 16080098
Curr Opin HIV AIDS. 2017 Jan;12(1):6-11
pubmed: 27749369
Am J Public Health. 2014 Dec;104(12):e12-22
pubmed: 25322302
Cochrane Database Syst Rev. 2016 Dec 21;12:CD004371
pubmed: 28000212
Am J Prev Med. 2015 Apr;48(4):472-9
pubmed: 25700655
Am Heart J. 2007 Jun;153(6):918-24
pubmed: 17540191
Am J Hypertens. 1997 Apr;10(4 Pt 1):409-18
pubmed: 9128207
JAMA Cardiol. 2017 Feb 1;2(2):155-162
pubmed: 28002550
Ann Intern Med. 2006 Aug 1;145(3):165-75
pubmed: 16880458
Jt Comm J Qual Patient Saf. 2013 Aug;39(8):371-82
pubmed: 23991510
HIV Med. 2017 Aug;18(7):463-473
pubmed: 28004523
Clin Infect Dis. 2016 Dec 1;63(11):1508-1516
pubmed: 27613562
Ann Intern Med. 2015 Mar 3;162(5):335-44
pubmed: 25732274
AIDS. 2012 Jan 28;26(3):335-43
pubmed: 22089374
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S58-71
pubmed: 24793443
Ann Intern Med. 2014 Jul 15;161(2):113-21
pubmed: 25023250
J Sch Health. 2000 Apr;70(4):141-7
pubmed: 10790837
Lancet. 2014 Jul 19;384(9939):241-8
pubmed: 25042234
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Cochrane Database Syst Rev. 2015 Mar 02;(3):CD006936
pubmed: 25726920
Clin Infect Dis. 2016 Oct 1;63(7):966-975
pubmed: 27358352
Clin Infect Dis. 2016 Oct 1;63(7):993-4
pubmed: 27369319
AIDS. 2017 Mar 13;31(5):681-688
pubmed: 28060020
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209
pubmed: 30423391
Curr Opin HIV AIDS. 2014 Jan;9(1):54-62
pubmed: 24275676
J Adv Nurs. 2010 Dec;66(12):2772-84
pubmed: 20831570
Clin Infect Dis. 2012 Dec;55(11):1550-7
pubmed: 22942209
J AIDS Clin Res. 2014 Nov;5(11):
pubmed: 25914854

Auteurs

Nwora Lance Okeke (NL)

Duke University School of Medicine, Durham, NC, USA.

Allison R Webel (AR)

Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA.

Hayden B Bosworth (HB)

Duke University School of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA.

Angela Aifah (A)

New York University School of Medicine, New York, NY, USA.

Gerald S Bloomfield (GS)

Duke University School of Medicine, Durham, NC, USA.

Emily W Choi (EW)

The University of Texas at Dallas, Dallas, TX, USA.

Sarah Gonzales (S)

Duke University School of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA.

Sarah Hale (S)

Duke University School of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA.

Corrilynn O Hileman (CO)

Case Western Reserve University School of Medicine, Cleveland, OH, USA; MetroHealth Medical Center, Cleveland, OH, USA.

Virginie Lopez-Kidwell (V)

University of North Texas, Denton, TX, USA.

Charles Muiruri (C)

Duke University School of Medicine, Durham, NC, USA.

Megan Oakes (M)

Duke University School of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA.

Julie Schexnayder (J)

Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA.

Valerie Smith (V)

Duke University School of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA.

Rajesh Vedanthan (R)

New York University School of Medicine, New York, NY, USA.

Chris T Longenecker (CT)

Case Western Reserve University School of Medicine, Cleveland, OH, USA; University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH, USA. Electronic address: cxl473@case.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH